Therefore, anti-angiogenesis is one of the necessary strategies for the treatment of HCC, and looking for a novel VEGFA regulator that controls the expression of endogenous VEGFA involved in various tumor progression in HCC, would contribute to find a novel therapeutic target for HCC. This evidence concerns the gene VEGFA and neoplasm.